Form 4: Procter & Gamble Executive Acquires Stock Options
SEC Form 4 Filing
Alexandra Keith, CEO Beauty at Procter & Gamble, reports acquisition of stock options and changes in beneficial ownership of common stock.
Summary
- Alexandra Keith, CEO Beauty at Procter & Gamble, filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 2,049 stock options with an exercise price of $174.08, exercisable from September 13, 2027, and expiring on September 13, 2034.
- The filing also shows direct ownership of 17,453.1608 shares of common stock.
- Indirect ownership includes 4,241.9748 shares held by spouse, 4,602.8004 shares held by Retirement Plan Trustee, and 2,493.8669 shares held by spouse and Retirement Plan Trustee.
Sentiment
Score: 6
Explanation: The document is a routine SEC filing related to executive compensation. It doesn't contain any information that would significantly impact investor sentiment positively or negatively. The acquisition of stock options is a standard practice.
Positives
- The acquisition of stock options by a high-ranking executive could be interpreted as a positive sign, indicating confidence in the company's future performance.
Industry Context
Executive stock option grants are a common practice in publicly traded companies like Procter & Gamble to incentivize and align management's interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in large, publicly traded companies such as Procter & Gamble.
- Companies like Unilever, Nestle, and Johnson & Johnson also utilize stock options as part of their executive compensation strategy.
- The specific terms of the options, such as the exercise price and vesting schedule, are typically determined by the company's compensation committee and are benchmarked against industry peers.
Stakeholder Impact
- The acquisition of stock options by a key executive could have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of earliest transaction and grant date of stock options. |
| 09/13/2027 | Date the stock options become exercisable. |
| 09/13/2034 | Expiration date of the stock options. |
| 09/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.